FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

22112311000001107: Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73213401000001110 Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73213501000001114 Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has specific active ingredient Tafamidis meglumine true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Is a Tafamidis meglumine 20mg capsules 30 capsule true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has AMP Vyndaqel 20mg capsules (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start